News and Events - Affimed

News

All categories

Earnings

Press Release

All years

2022

2021

2020

2019

2018

2017

2016

2015

2014

Affimed and MD Anderson Announce Clinical Immuno- Oncology Development Collaboration

January 4, 2017

Affimed Presents New Preclinical Data on Bi- and Trispecific Immune Cell Engagers at ASH

December 6, 2016

Affimed to Present at the Jefferies 2016 London Healthcare Conference

November 9, 2016

Affimed to Present Preclinical Data on Bi- and Trispecific Immune Cell Engagers at ASH

November 8, 2016

Affimed Reports Financial Results for Third Quarter 2016

November 2, 2016

Affimed to Present at the Credit Suisse 25th Annual Healthcare Conference

October 31, 2016

Affimed Announces Third Quarter 2016 Financial Results and Corporate Update Conference Call

October 26, 2016

Affimed Presents Preclinical Data on Lead Candidate AFM13 at the Annual Meeting of the Society for Natural Immunity

October 4, 2016

Affimed to Present at the Leerink Partners Roundtable Series: Rare Disease & Immuno-Oncology

September 22, 2016

Affimed to Present at Upcoming Investor Conferences

September 1, 2016

Events

All

Scientific

Investors

29Mar

Innate Killer Summit

March 29 - April 1, 2022 (San Diego, CA)

Webcasts More events